Modeling and simulation (M&S) was employed to recommend doses for human Phase I studies of a direct Factor Xa (FXa) inhibitor, CS-3030. Predicted human.
Y OUNG I NNOVATORS 2011 Population Pharmacokinetic and Pharmacodynamic Model- based Comparability Assessment of a Recombinant Human Epoetin Alfa and the.
Utilizing PKPD to Optimize Therapy
A Winning Strategy On Data Quality - Putting the Right Pieces Together
